Showing results (141-150 of 171) with videos related to
Sort By:
Pageof 18
Cancer Research|January 2, 2009
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cellsTasnim Ara, Liping Song, Hiroyuki Shimada, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 28, 2020
Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditionsHadley Stevens Smith, John M Swint, Seema R Lalani, et al.Proteomics. Clinical Applications|August 12, 2011
An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoringRachel A Egler, Yiting Li, Tu Anh T Dang, et al.Orthopedics|August 18, 2017
Extent and Morbidity of Lateralization of a Trochanteric Fixation Nail BladePhillip A Sandifer, Robert M Hulick, Matthew L Graves, et al.Orthopedics|August 14, 2010
Is obesity protective against wound healing complications in pilon surgery? Soft tissue envelope and pilon fractures in the obeseMatthew L Graves, Scott E Porter, Bryan C Fagan, et al.BMC Medical Informatics and Decision Making|October 3, 2014
Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admissionHeidi V Russell, M Fatih Okcu, Kala Kamdar, et al.Journal of Orthopaedic Trauma|August 8, 2018
Risk Factors for Kidney Dysfunction With the Use of Gentamicin in Open Fracture Antibiotic TreatmentJacob Folse, Charles E Hill, Matthew L Graves, et al.Plos One|December 13, 2007
Sexual risk behaviors for HIV/AIDS in Chuuk State, Micronesia: the case for HIV prevention in vulnerable remote populationsToya V Russell, Ann N Do, Eleanor Setik, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 16, 2018
Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the LiteratureHadley Stevens Smith, J Michael Swint, Seema R Lalani, et al.Molecular Cancer Therapeutics|August 13, 2009
Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastomaXiaoying Shang, Susan M Burlingame, M Fatih Okcu, et al.Pageof 18